ReviewThe multifaceted therapeutic potential of benfotiamine
Graphical abstract
Introduction
Nutritional deficiency is considered to be a major health burden affecting the routine life style of human beings in developing countries. Thiamine is a water-soluble vitamin found mainly in cereals, legumes, dried beans, soybeans, nuts, fortified breads, and lean meats and fish. Thiamine plays a key role in cellular energy metabolism as it helps in the process of conversion of carbohydrates into energy. Thiamine is required for normal functioning of the heart, muscles and nerves, and its intake is beneficial in the treatment of certain metabolic disorders [1], [2]. Benfotiamine is a lipid-soluble thiamine precursor having much higher bioavailability than genuine thiamine [3], [4]. Growing body of evidence revealed that benfotiamine alleviates the severity of diabetic complications such as neuropathy, nephropathy and retinopathy by inhibiting the formation of advanced glycation end products (AGEs) [3], [5], [6]. Benfotiamine prevents the progression of diabetic complications by increasing tissue levels of thiamine diphosphate, which enhances the transketolase activity that directs the precursors of AGEs to pentose phosphate pathway, resulting in the reduction of tissue levels of AGEs [7], [8], [9], [10]. Other beneficial effects of benfotiamine include improvement in cardiomyocyte contractile dysfunction in experimental diabetes mellitus [11], reduction in neuropathic pain [12], [13], [14] and improvement in experimental post-ischaemic healing [15]. Moreover, benfotiamine has been shown to reduce oxidative stress in a mechanism unrelated to its anti-AGE property [4]. In addition to its beneficial effects in preventing the progression of diabetic complications, benfotiamine has been demonstrated to prevent the induction of vascular endothelial dysfunction [9], [16], [17], [18], [19], which suggests the novel role of benfotiamine in improving the vascular functional regulation. Benfotiamine is absorbed in the body better than thiamine and in fact benfotiamine has better bioavailability than thiamine. Although benfotiamine has been shown to be similar to thiamine in correcting endothelial cell defects induced by high glucose [16], thiamine is needed to be administered at high dose as compared to benfotiamine to prevent the diabetic complications [8]. The present review critically discussed the wide array of recently revealed therapeutic potential of benfotiamine.
Section snippets
Pharmacology of benfotiamine
Thiamine-derived compounds were discovered from the plants of Allium genus such as onions, shallots and leeks and named as allithiamines [20]. The most effective compound of allithiamine family having the anti-AGEs property was subsequently identified and named as benfotiamine. The benfotiamine is a lipid-soluble congener of thiamine having a unique open thiazole-ringed structure that enables it to enter directly through the cell membrane resulting in enhanced bioavailability [21], [22], [23].
Formation of AGE products and their pathological implications: a fleeting look
Nonenzymatic protein glycation by glucose is a complex cascade of reactions yielding a heterogeneous class of compounds, collectively termed as AGEs. The AGEs are formed by nonenzymatic reaction between reducing sugars and amino acids on proteins, lipids and nucleic acids (Fig. 2). There are two major pathways in which AGEs can be formed in the biological system. One way is through a simple series of chemical reactions known as Maillard pathway (Fig. 3). The Maillard reaction begins with the
AGE-dependent and -independent pharmacological actions of benfotiamine
Benfotiamine, an inhibitor of the formation of AGEs, exerts its beneficial effects through a diverse mechanism. In diabetes, benfotiamine blocks three major biochemical pathways implicated in the pathogenesis of chronic hyperglycemia-induced vascular damage, i.e., hexosamine pathway, AGE formation pathway and diacylglycerol (DAG)–protein kinase C (PKC) pathway, which are activated by the high availability of the glycolytic metabolites such as glyceraldehyde-3-phosphate and fructose-6-phosphate
Novel therapeutic role of benfotiamine
Benfotiamine possesses much higher bioavailability than genuine thiamine that may uplift the preference of benfotiamine instead of thiamine for related therapeutic applications. Benfotiamine counteracts the damaging effects of hyperglycaemia on vascular cells that accounts for its beneficial defensive role in preventing diabetic complications [53]. As stated in previous section, benfotiamine has a therapeutic potential to halt the development of diabetes-induced neuropathy, nephropathy and
Concluding remarks
Benfotiamine has ability to halt the progression of many serious complications of prolonged hyperglycemia that certainly supports its therapeutic applications in diabetic patients. In fact, any bodily function improved by a therapeutic level of thiamine would most likely be enhanced by benfotiamine. The exaggerated benfotiamine consumption as a dietary supplement could over-stimulate the enzyme transketolase, which may account for some serious adverse drug reactions; however, the clear
Conflict of interest
The authors declared no conflict of interest.
Acknowledgment
The authors express their gratitude to Shri. S. Sriram Ashok Ji, B.E., Correspondent, and Shri. P. Dharmar Ji, Secretary of SB College of Pharmacy, Sivakasi, India for their inspiration and constant support to accomplish this study.
References (72)
- et al.
Benfotiamine alleviates diabetes-induced cerebral oxidative damage independent of advanced glycation end-product, tissue factor and TNF-alpha
Neurosci Lett
(2006) - et al.
Benfotiamine attenuates nicotine and uric acid-induced vascular endothelial dysfunction in the rat
Pharmacol Res
(2008) - et al.
Early glycation products produce pentosidine cross-links on native proteins
J Biol Chem
(2001) - et al.
Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine
Biochem Biophys Res Commun
(1996) - et al.
Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice
Atherosclerosis
(2003) - et al.
The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy
Metabolism
(2000) - et al.
Effects of a diet rich in advanced glycation end products in the rat remnant kidney model
Am J Kidney Dis
(2003) - et al.
Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus
Metabolism
(2006) - et al.
Advanced glycation endproduct induces ROS accumulation, apoptosis, MAP kinase activation and nuclear O-GlcNAcylation in human cardiac myocytes
Life Sci
(2007) - et al.
Benfotiamine relieves inflammatory and neuropathic pain in rats
Eur J Pharmacol
(2006)